NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Latest News In Electric Vehicles - Turbocharged Growth Ignites US Aftermarket Expansion

The U.S. electric vehicle (EV) aftermarket is projected to grow significantly, from $23.54 billion in 2024 to $99.19 billion by 2033, driven by a compound annual growth rate (CAGR) of 17.33%. This expansion is attributed to the increasing adoption of EVs, aging vehicle fleets, and heightened demand for components like batteries and charging stations. Technological advancements and initiatives by entities such as Bosch and ZF are further enhancing the aftermarket ecosystem. However, challenges...
NYSE:NU
NYSE:NUBanks

Nu Holdings (NU) Is Up 8.6% After Amazon Brazil Partnership and Record Q3 Results – What's Changed

Nu Holdings recently presented at the Bloomberg New Economy Forum in Singapore, announcing a partnership with Amazon Brazil to integrate NuPay and highlighting its record Q3 2025 results, with net income reaching US$783 million and a growing customer base of 127 million. This collaboration with Amazon further advances Nu’s presence in digital payments, while extensive customer growth underscores its position in Latin America’s evolving fintech landscape. We'll explore how the Amazon Brazil...
NYSE:O
NYSE:ORetail REITs

Is Realty Income a Hidden Value Play After Recent Retail Expansion News?

Ever wondered if Realty Income could be an undervalued gem hidden in plain sight? Let’s break down whether today’s price holds up against its true worth. The stock held steady this week with a 0.8% gain. Zooming out, returns are up 8.6% year-to-date, which may indicate shifting investor sentiment and potential for growth. Recent news about Realty Income’s continued expansion in retail real estate, including new acquisitions across key regions, has put the spotlight back on the company’s...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Is Now the Right Moment for Apple Stock as AI Momentum Lifts Shares 13.8% in 2025?

Wondering if Apple stock is still a smart buy, or if the price tag has outpaced its true value? You're not alone. Many investors are asking the same as headlines buzz and the market keeps moving. Apple's stock has climbed by 2.2% over the past week and is up an impressive 13.8% year-to-date, stoking optimism about its growth potential and shifting how some view its risk profile. In the broader tech landscape, news around product innovations and regulatory developments continues to shape...
NYSE:TPH
NYSE:TPHConsumer Durables

Tri Pointe Homes (TPH): Revisiting Valuation as Sales Slow and Profitability Pressures Mount

Recent coverage of Tri Pointe Homes (TPH) has drawn attention to its projected double-digit sales decline and shrinking backlog, as well as concerns over its profitability and strategic direction. The company’s valuation is now under scrutiny compared to competitors. See our latest analysis for Tri Pointe Homes. Tri Pointe Homes’ share price has shown a recent uptick, climbing over 7% in the last month after a steeper slide earlier this year. The one-year total shareholder return sits at a...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Do Teradyne’s Partnerships Justify Its 42% Rally in 2025?

Curious if Teradyne stock is a hidden bargain or simply priced for perfection? Let’s dig into what actually drives its value. Teradyne’s shares have been on a tear this year, up 41.7% year-to-date and boasting a 63.8% gain over the past twelve months. News has recently centered on Teradyne’s expansion into next-generation testing for semiconductor and automation markets, highlighting partnerships and technology launches. These developments have fueled optimism around its long-term prospects...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

Assessing TTM Technologies (TTMI) Valuation After Strong Share Price Gains

TTM Technologies (TTMI) has seen some intriguing moves in its stock price recently, catching the attention of investors focused on the tech manufacturing sector. The company’s shares reflect shifting sentiment after several weeks of steady gains. See our latest analysis for TTM Technologies. After an impressive run, TTM Technologies is riding high with its share price up 177.83% year-to-date and a three-year total shareholder return of 326.28%. The recent burst of momentum suggests renewed...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

Is Charter Communications Worth a Closer Look After a 49.7% Share Price Drop?

Thinking about whether Charter Communications is a bargain or overpriced? Let’s break down what’s been happening to help you figure out if now could be the right time to take a closer look. Charter’s share price has seen a sharp drop, down 17.3% over the past month and a hefty 49.7% over the last year. This might catch the attention of investors weighing potential risks or comeback opportunities. Recently, headlines have swirled around shifts in the U.S. cable and broadband industry. New...
NYSE:OMC
NYSE:OMCMedia

What Recent Account Wins Could Mean for Omnicom Group’s Stock in 2025

Thinking of buying Omnicom Group but not sure if it is a bargain? Let’s break down what the current numbers say about this media giant’s potential value. The stock hasn’t been friendly to shareholders lately, falling 4.5% over the past week and dropping 29.4% in the last year alone. Recently, headlines have focused on marketing sector shifts and changing client priorities, stirring up debates about Omnicom’s ability to adapt. News of major account wins along with the strategic push into...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike (CRWD): Assessing Valuation After Recent Share Price Decline and Strong Yearly Gains

CrowdStrike Holdings (CRWD) has been making waves in the cybersecurity landscape, with its share price swinging nearly 8% lower over the past month despite strong gains in the past year. See our latest analysis for CrowdStrike Holdings. CrowdStrike’s share price has cooled off recently, but momentum is still notable over the longer term. While the last 30 days saw an 8% share price decline, the year-to-date share price return is a robust 44%, and the company boasts an impressive 45% total...
NasdaqGS:CGEM
NasdaqGS:CGEMBiotechs

Cullinan Therapeutics (CGEM): Assessing Valuation Following FDA Submission for Zipalertinib Accelerated Approval

Cullinan Therapeutics has started a rolling submission with the FDA for accelerated approval of zipalertinib, its experimental drug for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. This regulatory step follows positive results from the Phase 1/2 REZILIENT1 trial and builds on the drug’s prior Breakthrough Therapy Designation. See our latest analysis for Cullinan Therapeutics. The momentum around Cullinan Therapeutics has turned noticeably positive this month,...